Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit (PATMORE)

Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care

This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria.

These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies.

It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.

Study Overview

• Status: Unknown
• Conditions: Transfusion Related Complication

• Study Type: Observational
• Enrollment (Anticipated): 150000

Contacts and Locations

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: ADULT; OLDER_ADULT; CHILD
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

All patients treated in medical and surgical resuscitation units of Besançon and Dijon university hospitals during the study period (from 01/01/2012 to 31/12/2017) are concerned.

Description

Inclusion criteria:

• Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered
• Patient admitted between 1st January 2012 to 31st December 2017

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Survival at 90 days after leaving ICU	All-cause mortality 90 days after leaving ICU	Day 90

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire de Besancon

Study record dates

Study Major Dates

• Study Start (ANTICIPATED): June 1, 2019
• Primary Completion (ANTICIPATED): December 1, 2020
• Study Completion (ANTICIPATED): December 1, 2020

Study Registration Dates

• First Submitted: April 26, 2019
• First Submitted That Met QC Criteria: April 30, 2019
• First Posted (ACTUAL): May 1, 2019

Study Record Updates

• Last Update Posted (ACTUAL): May 1, 2019
• Last Update Submitted That Met QC Criteria: April 30, 2019
• Last Verified: April 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: API/2016/72

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No